| 2023 |
陳思妤(Si-Yu Chen)、陳瑩儒(Ying-Ju Chen)、余志強(ER TZE KIONG)*, Retrospective study of lower respiratory tract infections in the intensive care unit detected by the FilmArray pneumonia panel, Clinical Laboratory, vol.0 no.0 pp.0-0, 2023 |
| 2023 |
陳瑩儒(Ying-Ju Chen)、陳志杰(Chih-Chieh Chen)、余志強(ER TZE KIONG)*, Cardiac markers and the incidence of cardiovascular disease in patients with chronic kidney disease, Advances in Clinical Chemistry, vol.0 no.0 pp.0-0, 2023 |
| 2023 |
曾煜威(Yu-Wei Tseng)、范姜晉偉(Jin-Wei Fan)、黃文豊(Wen-Li Hwang)、余志強(ER TZE KIONG), Interference of blood glucose testing by an increase in serum IgM levels, Clinical Laboratory, vol.2023 no.69 pp.0-0, 2023 |
| 2023 |
曾煜威(Yu-Wei Tseng)、范姜晉偉(Jin-Wei Fan Jiang)、余志強(ER TZE KIONG)*, Evaluation of Friedewald’s formula for plasma LDL-cholesterol estimation, Clinical Laboratory, vol.0 no.0 pp.0-0, 2023 |
| 2023 |
曾煜威(Yu-Wei Tseng)、陳志杰(Chih-Chieh Chen)、志強(余)*、余志強(ER TZE KIONG), To optimise blood culture volumes by implementing PDCA cycle management, Clinical Laboratory, vol.0 no.0 pp.0-0, 2023 |
| 2022 |
陳瑩儒(Ying-Ju Chen)、余志強(ER TZE KIONG), Distribution of viral respiratory infections during the COVID-19 pandemic using the FilmArray respiratory panel, Biomedicines, vol.10 no.11 pp.2734-0, 2022 |
| 2022 |
余志強(ER TZE KIONG)、陳志杰(Chih-Chieh Chen), Detection of the SARS-CoV-2 D614G mutation using VirSNiP SARS-CoV-2 Spike D614G assay, Clinical Laboratory, vol.2022 no.68 pp.1305-1308, 2022 |
| 2022 |
陳志杰(Chih-Chieh Chen)、周雍哲(CHOU,YUNG-CHE)、許珈旖(Chia-Yi Hsu)、蔡英美(Eing-Mei Tsai)、余志強(ER TZE KIONG), Transcriptome profiling of eutopic and ectopic endometrial stromal cells in women with endometriosis based on high throughput sequencing, Biomedicines, vol.10 no.10 pp.2432-, 2022 |
| 2021 |
余志強(ER TZE KIONG)*、陳思妤(Si-Yu Chen)、陳冠妤(Guan-Yu Chen), Analytical performance of the VIDASR BRAHMS procalcitonin assay and Beckman Coulter UnicelR DXI procalcitonin assay in a stat laborator, Clinical Laboratory, vol.67 no.3 pp.873-875, 2021 |
| 2021 |
余志強(ER TZE KIONG)*, A comparison of two molecular methods for detecting CALR mutations in myeloproliferative neoplasms, Clinical Laboratory, vol.67 no.0 pp.2018-2023, 2021 |
| 2021 |
余志強(ER TZE KIONG)*、周雍哲(Yung-Che Chou)、陳思妤(Si-Yu Chen)、黃健維(Jian-Wei Huang), Rapid cobas Liat SARS-CoV-2 assay in comparison with the laboratory-developed real-time RT-PCR test, Clinical Laboratory, vol.2021 no.67 pp.0-0, 2021 |
| 2021 |
余志強(ER TZE KIONG)*、陳思妤(Si-Yu Chen)、周雍哲(Yung-Che Chou)、黃健維(Jian-Wei Huang), Comparison of manual and automated nucleic acid extraction methods in virus transport medium, Clinical Laboratory, vol.67 no.0 pp.0-0, 2021 |
| 2019 |
Chih-Chieh Chen、Eing-Mei Tsai、余志強(ER TZE KIONG)*, Endometriosis-associated ovarian cancer: What have we learned so far?, CLINICA CHIMICA ACTA, vol.493 no.0 pp.63-72, 2019 |
| 2019 |
Yu-Fa Su、Eing-Mei Tsai、Chih-Chieh Chen、Chun-Chieh Wu、余志強(ER TZE KIONG)*, Targeted sequencing of a specific gene panel detects a high frequency of ARID1A and PIK3CA mutations in ovarian clear cell carcinoma, CLINICA CHIMICA ACTA, vol.494 pp.1-7, 2019 |
| 2019 |
林志隆、余志強(ER TZE KIONG)*, Identification of a case with heterozygous mutations in the FUT1 gene leading to a para-Bombay phenotype, Clinical Laboratory, vol.65 no.0 pp.2435-2437, 2019 |
| 2018 |
余志強(ER TZE KIONG)*、楊道杰(Tao-Chieh Yang)、劉奕泓(Yi-Hong Liu), Heterozygous FUT1 mutations causing a para-Bombay phenotype, Clinical Laboratory, vol.0, 2018 |
| 2018 |
Chia?Yi Hsu、Tsung?Hua Hsieh、余志強(ER TZE KIONG)、Hung?Sheng Chen、Ching?Chou Tsai、Eing?Mei Tsai, MiR?381 regulates cell motility, growth and colony formation through PIK3CA in endometriosis?associated clear cell and endometrioid ovarian cancer, ONCOLOGY REPORTS, vol.0 no.0 pp.0-0, 2018 |
| 2018 |
蘇郁法(YU-FA SU)、詹子嫻(TZE-HSIEN CHAN)、余志強(ER TZE KIONG)*, Analytical performance of the VIDASR High-sensitivity Troponin I assay and the Beckman Coulter UnicelR DXI AccuTnI+3 assay in a stat laboratory, Clinical Laboratory, vol.0 no.0 pp.0-0, 2018 |
| 2017 |
余志強(ER TZE KIONG)*, A case of para-Bombay phenotype caused by homozygous mutation of FUT1 gene, Turkish Journal of Hematology, vol.34 pp.356-381, 2017 |
| 2016 |
余志強(ER TZE KIONG)、蘇郁法(YU-FA SU)、吳俊杰(Chun-Chieh Wu)、陳志杰(Chih-Chieh Chen)、王菁(Jing Wang)、謝宗樺(Tsung-Hua Hsieh)、陳婉姿(Wan-Tzu Chen)、陳怡庭(Yi-Ting Chen)、蔡英美(Eing-Mei Tsai)*、陳鴻昇(Hung-Sheng Chen), Targeted next-generation sequencing for molecular diagnosis of endometriosis -associated ovarian cancer, JOURNAL OF MOLECULAR MEDICINE-JMM, vol.94 no.7 pp.835-47, 2016 |
| 2016 |
Maria Sanchez-Castanon、余志強(ER TZE KIONG)、Luis Bujanda、Marta Herreros-Villanueva(Marta Herreros-Villanueva)*, Immunotherapy in colorectal cancer:What have we learned so far?, CLINICA CHIMICA ACTA no.460 pp.78-87, 2016 |
| 2015 |
余志強(ER TZE KIONG)、Lin CW、Liu TC、Chen CC、Wang LH、Hsieh LL、Tsai WC(Tsai WC)*, Increase EGFR Mutations Detection Rate in Lung Adenocarcinoma by Real-Time PCR Screening Followed by Direct Sequencing., APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, vol.23 no.5 pp.343-348, 2015 |
| 2015 |
余志強(ER TZE KIONG)、Lin YC、Yeh KT、Hung CH、Chang JG(Chang JG)*, Rapid Identification of FGFR2 Gene Mutations in Taiwanese Patients With Endometrial Cancer Using High-resolution Melting Analysis., APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, vol.23 no.7 pp.532-537, 2015 |
| 2015 |
余志強(ER TZE KIONG)、Herreros-Villanueva M、Bujanda L(Bujanda L)*, Retinoic Acid Reduces Stem Cell-Like Features in Pancreatic Cancer Cells., PANCREAS, vol.44 no.6 pp.918-924, 2015 |
| 2015 |
余志強(ER TZE KIONG)、Wang YY、Chen CC、Herreros-Villanueva M、Liu TC、Yuan SS(Yuan SS)*, Molecular characterization of oral squamous cell carcinoma using targeted next-generation sequencing, ORAL DISEASES no.21 pp.872-8, 2015 |
| 2014 |
余志強(ER TZE KIONG)、Chen CC、Chien YH、Liang WC、Kan TM、Jong YJ(Jong YJ)*, Development of a feasible assay for the detection of GAA mutations in patients with Pompe disease., CLINICA CHIMICA ACTA, vol.2014 no.429 pp.18-25, 2014 |
| 2014 |
余志強(ER TZE KIONG)、Chih-Chieh Chen、Marta Herreros-Villanueva(Marta Herreros-Villanueva)*, Clinical relevance of KRAS mutations in codon 13: where are we?, CANCER LETTERS, vol.343 no.1 pp.1-5, 2014 |
| 2014 |
余志強(ER TZE KIONG)*、Chang JG, KRAS mutations: analytical considerations, CLINICA CHIMICA ACTA, vol.2014 no.431 pp.211-20, 2014 |
| 2014 |
余志強(ER TZE KIONG)、Chih-Chieh Chen、Bujanda L、Marta Herreros-Villanueva(Marta Herreros-Villanueva)*, Current approaches for predicting a lack of response to anti-EGFR therapy in KRAS wild-type patients., Biomed Research International, vol.2014 no.0 pp.591867(1-8-, 2014 |
| 2014 |
余志強(ER TZE KIONG)、Chang YS、Lu HC、Yeh KT、Chang JG(Chang JG)*, Detection of KRAS codon 12 and 13 mutations by mutant-enriched PCR assay, CLINICA CHIMICA ACTA, vol.2014 no.436 pp.169-175, 2014 |
| 2014 |
余志強(ER TZE KIONG)、Tsai SY、Lin CW、Chang Jg(Chang Jg)*, Comprehensive analysis of UGT1A1 polymorphisms through high-resolution melting analysis and DNA sequencing., Clinical Laboratory, vol.60 no.6 pp.1015-1026, 2014 |
